APA (7th ed.) Citation

BT, M., L, Z., AC, d., C, Y., A, S., H, A., . . . Y, H. (2024). Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV. Pharmaceutics, 16(5), . https://doi.org/10.3390/pharmaceutics16050594

Chicago Style (17th ed.) Citation

BT, Mayer, et al. "Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People Without HIV." Pharmaceutics 16, no. 5 (2024). https://doi.org/10.3390/pharmaceutics16050594.

MLA (9th ed.) Citation

BT, Mayer, et al. "Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People Without HIV." Pharmaceutics, vol. 16, no. 5, 2024, https://doi.org/10.3390/pharmaceutics16050594.